Brain-Type Natriuretic Peptide and Amino-Terminal Pro-Brain-Type Natriuretic Peptide Discharge Thresholds for Acute Decompensated Heart Failure: A Systematic Review
- PMID: 27894126
- DOI: 10.7326/M16-1468
Brain-Type Natriuretic Peptide and Amino-Terminal Pro-Brain-Type Natriuretic Peptide Discharge Thresholds for Acute Decompensated Heart Failure: A Systematic Review
Abstract
Background: Acute decompensated heart failure (ADHF) requiring hospitalization is associated with high postdischarge mortality and readmission rates.
Purpose: To examine the association between achieving predischarge natriuretic peptide (NP) thresholds and mortality and readmission rates in adults hospitalized for ADHF.
Data sources: Multiple databases from 1947 to October 2016 (English-language studies only).
Study selection: Trials and observational studies that compared mortality and readmission outcomes between patients with ADHF achieving a specific predischarge NP goal and those not achieving the goal.
Data extraction: Two investigators independently extracted study characteristics and assessed study risk of bias. One author graded the overall strength of evidence, with review by a second author.
Data synthesis: One randomized trial, 3 quasi-experimental studies, and 40 observational studies were identified. The most commonly used thresholds were a brain-type NP (BNP) level of 250 pg/mL or less or an amino-terminal pro-brain-type NP (NT-proBNP) decrease of at least 30%. Achievement of absolute BNP thresholds reduced postdischarge all-cause mortality (7 of 8 studies) and the composite outcome of mortality and readmission (12 of 14 studies). Achievement of percentage-change BNP thresholds reduced the composite outcome (5 of 6 studies), and achievement of percentage-change NT-proBNP thresholds reduced all-cause and cardiovascular mortality (2 of 4 studies) and the composite outcome (9 of 9 studies). All findings were low-strength. The randomized trial, assessed as having high risk of bias, suggested that a predischarge decrease in NT-proBNP level was associated with lower risk for the composite outcome. Two quasi-experimental studies and 5 observational studies had low risk of bias. Low-risk-of-bias studies had outcome estimates similar in magnitude and direction to estimates from high-risk-of-bias studies.
Limitation: Most studies failed to adjust for critical confounders and had inadequate definition or assessment of exposures and outcomes.
Conclusion: Low-strength evidence suggests an association between achieving NP predischarge thresholds and reduced ADHF mortality and readmission.
Primary funding source: None.
Comment in
-
Inpatient Management of Heart Failure: Are We Shooting at the Right Target?Ann Intern Med. 2017 Feb 7;166(3):223-224. doi: 10.7326/M16-2667. Epub 2016 Nov 29. Ann Intern Med. 2017. PMID: 27894128 No abstract available.
-
Brain-Type Natriuretic Peptide and Amino-Terminal Pro-Brain-Type Natriuretic Peptide Discharge Thresholds for Acute Decompensated Heart Failure.Ann Intern Med. 2017 Jun 20;166(12):915. doi: 10.7326/L17-0193. Ann Intern Med. 2017. PMID: 28630986 No abstract available.
-
Brain-Type Natriuretic Peptide and Amino-Terminal Pro-Brain-Type Natriuretic Peptide Discharge Thresholds for Acute Decompensated Heart Failure.Ann Intern Med. 2017 Jun 20;166(12):916. doi: 10.7326/L17-0194. Ann Intern Med. 2017. PMID: 28630987 No abstract available.
Similar articles
-
NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).Circulation. 2018 Apr 17;137(16):1671-1683. doi: 10.1161/CIRCULATIONAHA.117.029882. Epub 2017 Dec 14. Circulation. 2018. PMID: 29242350 Clinical Trial.
-
A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score.Heart. 2014 Jan;100(2):115-25. doi: 10.1136/heartjnl-2013-303632. Epub 2013 Oct 31. Heart. 2014. PMID: 24179162
-
Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-PRoBNP target on the reduction of readmIssion and Mortality rAtes.Am Heart J. 2014 Jul;168(1):30-6. doi: 10.1016/j.ahj.2014.04.008. Epub 2014 Apr 23. Am Heart J. 2014. PMID: 24952857 Clinical Trial.
-
The predictive value of plasma biomarkers in discharged heart failure patients: role of plasma NT-proBNP.Minerva Cardioangiol. 2016 Apr;64(2):157-64. Epub 2015 Sep 15. Minerva Cardioangiol. 2016. PMID: 26373781 Review.
-
Effectiveness of serial increases in amino-terminal pro-B-type natriuretic peptide levels to indicate the need for mechanical circulatory support in children with acute decompensated heart failure.Am J Cardiol. 2011 Feb 15;107(4):573-8. doi: 10.1016/j.amjcard.2010.10.015. Am J Cardiol. 2011. PMID: 21295174 Review.
Cited by
-
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart Int. 2023 Nov 23;17(2):35-42. doi: 10.17925/HI.2023.17.2.3. eCollection 2023. Heart Int. 2023. PMID: 38455673 Free PMC article. Review.
-
Different expression and prognostic value of troponin in ischemic cardiomyopathy and non-ischemic dilated cardiomyopathy.Eur J Med Res. 2023 Jul 3;28(1):220. doi: 10.1186/s40001-023-01169-5. Eur J Med Res. 2023. PMID: 37400933 Free PMC article.
-
Prognostic impact of a reduction in the fibrosis-4 index among patients hospitalized with acute heart failure.Heart Vessels. 2023 Oct;38(10):1235-1243. doi: 10.1007/s00380-023-02273-6. Epub 2023 Jun 6. Heart Vessels. 2023. PMID: 37277568
-
Impact of the degree of worsening renal function and B-type natriuretic peptide on the prognosis of patients with acute heart failure.Front Cardiovasc Med. 2023 Apr 3;10:1103813. doi: 10.3389/fcvm.2023.1103813. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37077744 Free PMC article.
-
Treatment response in recent-onset heart failure with reduced ejection fraction: non-ischaemic vs. ischaemic aetiology.ESC Heart Fail. 2023 Feb;10(1):542-551. doi: 10.1002/ehf2.14214. Epub 2022 Nov 4. ESC Heart Fail. 2023. PMID: 36331067 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous